肥胖、肌少症与肌少性肥胖增加高血压风险:炎症和胰岛素抵抗的中介作用
完全调整模型显示,与无上述情况的男性相比,肥胖、肌少症和肌少性肥胖者发生高血压的风险分别高2.32倍、3.10倍和3.66倍;女性分别高2.27倍、2.93倍和4.04倍。C反应蛋白、中性粒细胞、白细胞、甘油三酯-葡萄糖指数及甘油三酯与高密度脂蛋白胆固醇比值存在显著中介效应。
要点
- 肌少性肥胖者高血压风险最高,男性3.66倍、女性4.04倍。
- 炎症指标和胰岛素抵抗部分中介肌少性肥胖与高血压的关联。
- 肥胖和肌少症单独亦显著增加高血压风险。
核心结论
- 肥胖、肌少症和肌少性肥胖均显著增加高血压风险。
- 炎症和胰岛素抵抗似乎在肌少性肥胖与高血压的关联中起中介作用。
研究设计与样本
- 利用英国生物银行大规模前瞻性队列数据。
- 肥胖按脂肪质量百分比定义,肌少症定义为低肌肉量和低肌肉力量。
- 主要结局为5年随访期间新发高血压,采用Cox回归模型分析关联。
主要发现
- 完全调整模型中,男性肥胖、肌少症、肌少性肥胖者高血压风险分别为无上述情况者的2.32倍(95%CI 2.12-2.55)、3.10倍(95%CI 2.35-4.08)、3.66倍(95%CI 2.98-4.50)。
- 女性肥胖、肌少症、肌少性肥胖者高血压风险分别为2.27倍(95%CI 2.03-2.54)、2.93倍(95%CI 1.95-4.39)、4.04倍(95%CI 3.32-4.91)。
- C反应蛋白、中性粒细胞、白细胞、甘油三酯-葡萄糖指数及甘油三酯与高密度脂蛋白胆固醇比值存在显著中介效应。
- 肌少性肥胖与高血压关联的中介比例男性为6%至13%,女性为2%至21%。
关键数值与推荐
- 肥胖定义采用脂肪质量百分比。
- 肌少症定义为低肌肉量和低肌肉力量。
- 高血压风险比值比及95%CI如上所述,来自完全调整Cox回归模型。
临床怎么用
- 老年医学科评估高血压风险时应关注肥胖、肌少症及肌少性肥胖的共存。
- 对肌少性肥胖患者可考虑监测炎症指标和胰岛素抵抗相关指标。
- 针对炎症和胰岛素抵抗的干预可能有助于降低肌少性肥胖患者的高血压风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to assess the association between obesity, sarcopenia, and sarcopenic obesity with hypertension and to explore the potential mediation of inflammation indicators and insulin resistance. METHODS: Data from the UK Biobank, a large-scale prospective cohort, were utilized. Obesity was defined using percentage of fat mass, whereas sarcopenia was defined as low muscle mass and low muscle strength. The primary outcome assessed was new-onset hypertension within a 5-year follow-up period. The association analysis was examined using a Cox regression model. RESULTS: A total of 183 091 participants were enrolled in this study. During 5 years of follow-up, 3 812 (2.08%) developed hypertension. In the fully adjusted model, compared to men without these conditions, those with obesity, sarcopenia, and sarcopenic obesity had 2.32 times (95% confidence interval [95% CI], 2.12-2.55), 3.10 times (95% CI, 2.35-4.08), and 3.66 times (95% CI, 2.98-4.50) higher risks of developing hypertension, respectively. Women with obesity, sarcopenia, and sarcopenic obesity had 2.27 times (95% CI, 2.03-2.54), 2.93 times (95% CI, 1.95-4.39), and 4.04 times (95% CI, 3.32-4.91) higher risks of hypertension, respectively. Significant mediating effects of C-reactive protein, neutrophils, white blood cells, triglyceride-glucose index, and triglyceride-to-high-density lipoprotein cholesterol ratio were found, with mediations ranging from 6% to 13% for men and 2% to 21% for women in the association between sarcopenic obesity and hypertension. CONCLUSIONS: Obesity, sarcopenia, and sarcopenic obesity significantly increased the risk of hypertension. Inflammation and insulin resistance appeared to mediate the association between sarcopenic obesity and hypertension.
引用
- Zou Y, Ye H, Xu Z, et al. Obesity, Sarcopenia, Sarcopenic Obesity, and Hypertension: Mediating Role of Inflammation and Insulin Resistance. J Gerontol A Biol Sci Med Sci. 2025. PMID: 39918389. doi:10.1093/gerona/glae284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。